SYNERON MEDICAL LTD - ORD SHS (ELOS)

CUSIP: M87245102

Q1 2015 13F Holders as of 31 Mar 2015

Type / Class
Equity / ORD SHS
Total 13F shares
25,776,952
Share change
-1,212,106
Total reported value
$318,977,343
Price per share
$12.38
Number of holders
77
Value change
-$6,490,386
Number of buys
46
Number of sells
20

Quarterly Holders Quick Answers

What is CUSIP M87245102?
CUSIP M87245102 identifies ELOS - SYNERON MEDICAL LTD - ORD SHS in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of SYNERON MEDICAL LTD - ORD SHS (ELOS) as of Q1 2015

As of 31 Mar 2015, SYNERON MEDICAL LTD - ORD SHS (ELOS) was held by 77 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 25,776,952 shares. The largest 10 holders included Senvest Management, LLC, NORTH TIDE CAPITAL, LLC, JPMORGAN CHASE & CO, Visium Asset Management, LP, SENZAR ASSET MANAGEMENT, LLC, Broadfin Capital, LLC, DALTON GREINER HARTMAN MAHER & CO, GRANAHAN INVESTMENT MANAGEMENT INC/MA, BRANDES INVESTMENT PARTNERS, LP, and RENAISSANCE TECHNOLOGIES LLC. This page lists 77 institutional shareholders reporting positions in this security for the Q1 2015 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.